4//SEC Filing
GASPARINI ROBERT P 4
Accession 0001144204-13-027036
CIK 0001077183other
Filed
May 7, 8:00 PM ET
Accepted
May 8, 3:54 PM ET
Size
10.4 KB
Accession
0001144204-13-027036
Insider Transaction Report
Form 4
GASPARINI ROBERT P
DirectorChief Science Officer
Transactions
- Sale
Common Stock
2013-05-02$3.60/sh−2,500$9,000→ 10,000 total
Holdings
- 100,000
Stock Option (right to buy)
Exercise: $1.47From: 2007-02-13Exp: 2017-02-12→ Common Stock (0 underlying) - 584,000
Stock Option (right to buy)
Exercise: $0.80From: 2008-03-12Exp: 2015-03-12→ Common Stock (0 underlying) - 150,000
Stock Option (right to buy)
Exercise: $0.62From: 2009-12-31Exp: 2016-02-01→ Common Stock (0 underlying) - 525,000
Stock Option (right to buy)
Exercise: $0.25From: 2005-01-03Exp: 2015-01-03→ Common Stock (0 underlying)
Footnotes (2)
- [F1]On March 12, 2008 Mr. Gasparini was granted an option to purchase 784,000 shares. The first vesting and exercisable date was March 12, 2008. On this date 24,000 options vested and then there was to be 45 additional monthly vesting of 8,000 shares for a total of 384,000 options. Included in this grant were 400,000 non-qualified options with an initial vesting on March 12, 2008. From this grant 200,000 options were cancelled. In terms of the remaining 200,000 non-qualified options, 100,000 options are vested and exercisable.
- [F2]On February 2, 2009 Mr. Gasparini was granted an option to purchase 200,000 shares. These were performance options which vest based on various milestones. To date 50,000 shares are vested and exercisable, 50,000 shares have been cancelled and 100,000 shares are unvested.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001518647
Filing Metadata
- Form type
- 4
- Filed
- May 7, 8:00 PM ET
- Accepted
- May 8, 3:54 PM ET
- Size
- 10.4 KB